403 related articles for article (PubMed ID: 28130115)
1. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
Alquraini H; Auchus RJ
Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
[TBL] [Abstract][Full Text] [Related]
2. Androgenic-anabolic steroids and the Olympic Games.
Fitch KD
Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
[TBL] [Abstract][Full Text] [Related]
3. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
4. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
Huang G; Basaria S
Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
[TBL] [Abstract][Full Text] [Related]
5. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
Overbye M; Wagner U
Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
[TBL] [Abstract][Full Text] [Related]
6. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
Fitch K
Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
[TBL] [Abstract][Full Text] [Related]
7. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
Negro F; Di Trana A; Marinelli S
Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
[TBL] [Abstract][Full Text] [Related]
8. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
9. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
10. Anabolic-androgenic steroid dependence? Insights from animals and humans.
Wood RI
Front Neuroendocrinol; 2008 Oct; 29(4):490-506. PubMed ID: 18275992
[TBL] [Abstract][Full Text] [Related]
11. Effects of androgenic-anabolic steroids in athletes.
Hartgens F; Kuipers H
Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
[TBL] [Abstract][Full Text] [Related]
12. Anabolic-androgenic steroids and testosterone precursors: ergogenic aids and sport.
Foster ZJ; Housner JA
Curr Sports Med Rep; 2004 Aug; 3(4):234-41. PubMed ID: 15231229
[TBL] [Abstract][Full Text] [Related]
13. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
14. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
Geyer H; Schänzer W; Thevis M
Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
[TBL] [Abstract][Full Text] [Related]
15. A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico.
Acevedo P; Jorge JC; Cruz-Sánchez A; Amy E; Barreto-Estrada JL
West Indian Med J; 2011 Oct; 60(5):531-5. PubMed ID: 22519228
[TBL] [Abstract][Full Text] [Related]
16. Advances in the detection of designer steroids in anti-doping.
Abushareeda W; Fragkaki A; Vonaparti A; Angelis Y; Tsivou M; Saad K; Kraiem S; Lyris E; Alsayrafi M; Georgakopoulos C
Bioanalysis; 2014 Mar; 6(6):881-96. PubMed ID: 24702116
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of anabolic androgenic steroids.
Schänzer W
Clin Chem; 1996 Jul; 42(7):1001-20. PubMed ID: 8674183
[TBL] [Abstract][Full Text] [Related]
18. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
[TBL] [Abstract][Full Text] [Related]
19. Use of doping agents, particularly anabolic steroids, in sports and society.
Sjöqvist F; Garle M; Rane A
Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Use Exemptions.
Gerrard D; Pipe A
Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
